172 related articles for article (PubMed ID: 9951556)
1. Cytotoxic activity of BCG-activated macrophages against L929 tumor cells is nitric oxide-dependent.
Nascimento FR; Ribeiro-Dias F; Russo M
Braz J Med Biol Res; 1998 Dec; 31(12):1593-6. PubMed ID: 9951556
[TBL] [Abstract][Full Text] [Related]
2. Cellular models of macrophage tumoricidal effector mechanisms in vitro. Characterization of cytolytic responses to tumor necrosis factor and nitric oxide pathways in vitro.
Klostergaard J; Leroux ME; Hung MC
J Immunol; 1991 Oct; 147(8):2802-8. PubMed ID: 1918993
[TBL] [Abstract][Full Text] [Related]
3. TNF-alpha controls intracellular mycobacterial growth by both inducible nitric oxide synthase-dependent and inducible nitric oxide synthase-independent pathways.
Bekker LG; Freeman S; Murray PJ; Ryffel B; Kaplan G
J Immunol; 2001 Jun; 166(11):6728-34. PubMed ID: 11359829
[TBL] [Abstract][Full Text] [Related]
4. Entamoeba histolytica modulates the nitric oxide synthase gene and nitric oxide production by macrophages for cytotoxicity against amoebae and tumour cells.
Wang W; Keller K; Chadee K
Immunology; 1994 Dec; 83(4):601-10. PubMed ID: 7533135
[TBL] [Abstract][Full Text] [Related]
5. Tumoricidal effector mechanisms of murine BCG-activated macrophages: role of TNF in conjugation-dependent and conjugation-independent pathways.
Klostergaard J; Stoltje PA; Kull FC
J Leukoc Biol; 1990 Sep; 48(3):220-8. PubMed ID: 2167918
[TBL] [Abstract][Full Text] [Related]
6. Role of cytokines and nitric oxide in the induction of tuberculostatic macrophage functions.
Petricevich VL; Alves RC
Mediators Inflamm; 2000; 9(6):261-9. PubMed ID: 11213909
[TBL] [Abstract][Full Text] [Related]
7. Interferon regulatory factor (IRF)-1 is a master regulator of the cross talk between macrophages and L929 fibrosarcoma cells for nitric oxide dependent tumoricidal activity.
Nascimento FR; Gomes EA; Russo M; Lepique AP
PLoS One; 2015; 10(2):e0117782. PubMed ID: 25659093
[TBL] [Abstract][Full Text] [Related]
8. Differential inhibition of RAW264.7 macrophage tumoricidal activity by delta 9tetrahydrocannabinol.
Burnette-Curley D; Cabral GA
Proc Soc Exp Biol Med; 1995 Oct; 210(1):64-76. PubMed ID: 7675800
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-10 inhibits Mycobacterium bovis bacillus Calmette-Guérin (BCG)-induced macrophage cytotoxicity against bladder cancer cells.
Luo Y; Han R; Evanoff DP; Chen X
Clin Exp Immunol; 2010 Jun; 160(3):359-68. PubMed ID: 20148913
[TBL] [Abstract][Full Text] [Related]
10. Neutralization of gamma interferon and tumor necrosis factor alpha blocks in vivo synthesis of nitrogen oxides from L-arginine and protection against Francisella tularensis infection in Mycobacterium bovis BCG-treated mice.
Green SJ; Nacy CA; Schreiber RD; Granger DL; Crawford RM; Meltzer MS; Fortier AH
Infect Immun; 1993 Feb; 61(2):689-98. PubMed ID: 8423095
[TBL] [Abstract][Full Text] [Related]
11. Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms.
Cui S; Reichner JS; Mateo RB; Albina JE
Cancer Res; 1994 May; 54(9):2462-7. PubMed ID: 8162595
[TBL] [Abstract][Full Text] [Related]
12. Involvement of NO, H2O2 and TNF-alpha in the reduced antitumor activity of murine peritoneal macrophages by aflatoxin B1.
Moon EY; Rhee DK; Pyo S
Cancer Lett; 1999 Mar; 136(2):167-76. PubMed ID: 10355746
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin primes murine peritoneal macrophages for enhanced expression of nitric oxide, proinflammatory cytokines, TLRs, transcription factors and activation of MAP kinases upon co-incubation with L929 cells.
Chauhan P; Sodhi A; Shrivastava A
Immunobiology; 2009; 214(3):197-209. PubMed ID: 19215802
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide production by peritoneal macrophages of Mycobacterium bovis BCG-infected or non-infected mice: regulatory role of T lymphocytes and cytokines.
Saito S; Nakano M
J Leukoc Biol; 1996 Jun; 59(6):908-15. PubMed ID: 8691077
[TBL] [Abstract][Full Text] [Related]
15. IFN-gamma-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-alpha.
Langermans JA; Van der Hulst ME; Nibbering PH; Hiemstra PS; Fransen L; Van Furth R
J Immunol; 1992 Jan; 148(2):568-74. PubMed ID: 1729374
[TBL] [Abstract][Full Text] [Related]
16. Iron down-regulates macrophage anti-tumour activity by blocking nitric oxide production.
Harhaji L; Vuckovic O; Miljkovic D; Stosic-Grujicic S; Trajkovic V
Clin Exp Immunol; 2004 Jul; 137(1):109-16. PubMed ID: 15196250
[TBL] [Abstract][Full Text] [Related]
17. Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target.
Jiang H; Stewart CA; Fast DJ; Leu RW
J Immunol; 1992 Sep; 149(6):2137-46. PubMed ID: 1517576
[TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis of macrophages: a potential way to identify novel proteins associated with activation of macrophages for tumor cell killing.
Zhang L; Zhu H; Lun Y; Yan D; Yu L; Du B; Zhu X
Cell Mol Immunol; 2007 Oct; 4(5):359-67. PubMed ID: 17976316
[TBL] [Abstract][Full Text] [Related]
19. Cytolytic mechanisms of activated macrophages. Tumor necrosis factor and L-arginine-dependent mechanisms act synergistically as the major cytolytic mechanisms of activated macrophages.
Higuchi M; Higashi N; Taki H; Osawa T
J Immunol; 1990 Feb; 144(4):1425-31. PubMed ID: 2303713
[TBL] [Abstract][Full Text] [Related]
20. Induction of soluble antitumoral mediators by synthetic analogues of bacterial lipoprotein in bone marrow-derived macrophages from LPS-responder and -nonresponder mice.
Pfannes SD; Müller B; Körner S; Bessler WG; Hoffmann P
J Leukoc Biol; 2001 Apr; 69(4):590-7. PubMed ID: 11310845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
